November 10, 2018

The Performance Characteristics of Isolated Human Liver Cells Correlate With Donor Attributes in a Cohort of Tissues From Non-Diseased and NAFLD Donors

AASLD The Liver Meeting® 2018  |  Publication 1305

Samsara Sciences Poster Download

August 24, 2018

New Use of Niacin for the Treatment of NASH/Non-Alcoholic Fatty Liver Disease (NAFLD): Combination Therapy With Drugs in Development

NASH Summit 2018  |  Aasta Pharmaceuticals

“The data shows for the first time that, in human stellate cells from patients with NASH and fibrosis and a patient with non-NASH (normal control), niacin prevents and regresses collagen deposition.”  -Moti L. Kashyap

Samsara Sciences Poster Download


July 31, 2018

Liver-derived Endothelial Cells

A glass-based, continuously zonated and vascularized human liver acinus microphysiological system (vLAMPS) designed for experimental modeling of diseases and ADME/TOX

Li X, George SM, Vernetti L, Gough AH, Taylor DL | University of Pittsburgh
Lab Chip. 2018; 18(17):2614-2631.  doi: 10.1039/c8lc00418h

full text link


July 25, 2018

45 minutes

Isolation, Characterization, and use of DonorMatched™ Primary Human Liver Cells in the study of NAFLD/NASH

Sharon C. Presnell, PhD | President, Samsara | CSO, Organovo

Today’s research strategies in the study of human liver biology and disease require access to cell samples that capture the complexity of the tissue of origin as well as the heterogeneity of the human donor population. Matched sets of primary human cells are now available from a spectrum of donors, including patients with confirmed NAFLD/NASH. How are these reagents being utilized today? How might their availability power your research?